Kalaris Therapeutics, Inc. Cash Flow Reinvestment Rate
Kalaris Therapeutics, Inc. cash flow reinvestment rate. Kalaris Therapeutics, Inc. (KLRS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2018, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.94 Million. Explore KLRS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Kalaris Therapeutics, Inc. (2018–2018)
Cash flow reinvestment rate of Kalaris Therapeutics, Inc. from 2018 to 2018. Historical reinvestment intensity for Kalaris Therapeutics, Inc. across 1 annual periods. Also explore how fast is Kalaris Therapeutics, Inc. growing its equity to track the company's year-over-year net asset growth rate.
Kalaris Therapeutics, Inc. Cash Flow Reinvestment Rate by Year (2018–2018)
Kalaris Therapeutics, Inc. cash flow reinvestment rate by year from 2018 to 2018. Year-by-year capital reinvestment analysis for Kalaris Therapeutics, Inc.. For the full cash flow conversion analysis, see Kalaris Therapeutics, Inc. operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.00x | $0.00 | $1.94 Million | $0.00 | — |